Landmark study opens door to new cancer, aging treatments

Researchers at The Wistar Institute have deciphered the structure of the active region of telomerase, an enzyme that plays a major role in the development of nearly all human cancers. The landmark achievement opens the door to the creation of new, broadly effective cancer drugs, as well as anti-aging therapies.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news139410405.html">Landmark study opens door to new cancer, aging treatments</a></p> <p>Researchers at The Wistar Institute have deciphered the structure of the active region of telomerase, an enzyme that plays a major role in the development of nearly all human cancers. The landmark achievement opens the door to the creation of new, broadly effective cancer drugs, as well as anti-aging therapies.</p>